CAMP (Camp4 Therapeutics) Short-Term Capital Lease Obligation : $3.11 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Camp4 Therapeutics Short-Term Capital Lease Obligation?

Camp4 Therapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $3.11 Mil.

Camp4 Therapeutics's quarterly Short-Term Capital Lease Obligation declined from Sep. 2024 ($3.09 Mil) to Dec. 2024 ($3.09 Mil) but then increased from Dec. 2024 ($3.09 Mil) to Mar. 2025 ($3.11 Mil).

Camp4 Therapeutics's annual Short-Term Capital Lease Obligation increased from Dec. 2022 ($2.37 Mil) to Dec. 2023 ($3.06 Mil) and increased from Dec. 2023 ($3.06 Mil) to Dec. 2024 ($3.09 Mil).

Camp4 Therapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Camp4 Therapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camp4 Therapeutics Short-Term Capital Lease Obligation Chart

Camp4 Therapeutics Annual Data

Trend

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

2.37

3.06

3.09

Camp4 Therapeutics Quarterly Data
	Dec22	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial			-	3.10	3.09	3.09	3.11

Camp4 Therapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Camp4 Therapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Camp4 Therapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Camp4 Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camp4 Therapeutics Corp (NAS:CAMP) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA, USA

Website

https://www.camp4tx.com

Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.